Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term.

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

Ari Bousbib; Chairman of the Board, Chief Executive Officer; IQVIA Holdings Inc Ronald Bruehlman; Chief Financial Officer, Executive Vice President; IQVIA Holdings Inc Shlomo Rosenbaum; Analyst; ...

Analysts fell to the sidelines weighing in on IQVIA Holdings (IQV – Research Report) and Doximity (DOCS – Research Report) with neutral ...

Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

Bank of America Securities analyst Michael Ryskin maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today. The company’s shares ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

IQVIA Holdings Inc. IQV will release its fourth-quarter 2024 results on Feb. 6, before market open. See Zacks Earnings ...

Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions. Surbhi Jain Elliott Investment Management Adds To Southwest, Western Digital ...

Current political and economic issues succinctly explained. On February 1, President Donald Trump imposed tariffs on Canada, China, and Mexico—the United States’ largest trading partners. U.S ...

IQVIA also identified 438 feasibility studies looking at 933 distinct biomarkers last year, and 96 trials that used digital biomarkers as endpoints, as digital health tools continue to be inserted ...